Felicity C. Smith
Gold Coast, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Benefits of Adding Non-Antimuscarinic Pharmaceuticals in Combination With Beta-3 Agonists for Overactive Bladder Treatment: A Systematic Review.
Journal: Neurourology and urodynamics
Published: June 10, 2026
Adverse effects and discontinuation rates for darifenacin in overactive urinary bladder: a systematic review and meta-analysis of randomized controlled trials.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 26, 2025
The safety and pharmacokinetics of metformin in patients with chronic liver disease.
Journal: Alimentary pharmacology & therapeutics
Published: November 06, 2019
Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis.
Journal: British journal of clinical pharmacology
Published: June 03, 2019
Paediatric Salmonellosis-Differences between Tropical and Sub-Tropical Regions of Queensland, Australia.
Journal: Tropical medicine and infectious disease
Published: March 04, 2019
Lactic Acidosis, Metformin Use, and Dose-Response Association.
Journal: JAMA internal medicine
Published: October 05, 2018
Could metformin be used in patients with advanced chronic kidney disease?
Journal: Diabetes, obesity & metabolism
Published: October 06, 2016
Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: February 28, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026